{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:18:52Z","timestamp":1790313532093,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s00392-025-02630-7","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T08:56:28Z","timestamp":1747040188000},"page":"1087-1098","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evidence of bioprosthetic valve dysfunction during three-year follow-up following TAVR"],"prefix":"10.1007","volume":"115","clinical-trial-number":[{"clinical-trial-number":"nct01805739","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2744-2154","authenticated-orcid":false,"given":"Verena","family":"Veulemans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Heermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Adrichem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salome","family":"Hecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp C.","family":"Seppelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thijmen W.","family":"Hokken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rutger-Jan","family":"Nuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdel-Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas M","family":"van Mieghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Leistner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M.","family":"Vorpahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Zeus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2630_CR1","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1016\/S0140-6736(15)60308-7","volume":"385","author":"MJ Mack","year":"2015","unstructured":"Mack MJ, Leon MB, Smith CR, Miller DC, Moses JW, Tuzcu EM, Webb JG, Douglas PS, Anderson WN, Blackstone EH et al (2015) 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 385:2477\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(15)60308-7","journal-title":"Lancet."},{"key":"2630_CR2","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","volume":"380","author":"MJ Mack","year":"2019","unstructured":"Mack MJ, Leon MB, Thourani VH, Makkar R, Kodali SK, Russo M, Kapadia SR, Malaisrie SC, Cohen DJ, Pibarot P et al (2019) Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 380:1695\u20131705. https:\/\/doi.org\/10.1056\/NEJMoa1814052","journal-title":"N Engl J Med."},{"key":"2630_CR3","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","volume":"380","author":"JJ Popma","year":"2019","unstructured":"Popma JJ, Deeb GM, Yakubov SJ, Mumtaz M, Gada H, O\u2019Hair D, Bajwa T, Heiser JC, Merhi W, Kleiman NS et al (2019) Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 380:1706\u20131715. https:\/\/doi.org\/10.1056\/NEJMoa1816885","journal-title":"N Engl J Med."},{"key":"2630_CR4","doi-asserted-by":"publisher","first-page":"2717","DOI":"10.1016\/j.jacc.2021.02.038","volume":"77","author":"P G\u00e9n\u00e9reux","year":"2021","unstructured":"Varc-3 writing committee, G\u00e9n\u00e9reux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P et al (2021) Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol. 77:2717\u20132746. https:\/\/doi.org\/10.1016\/j.jacc.2021.02.038","journal-title":"J Am Coll Cardiol."},{"key":"2630_CR5","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1093\/eurheartj\/ehae043","volume":"45","author":"HGH Thyregod","year":"2024","unstructured":"Thyregod HGH et al (2024) Transcatheter or surgical aortic valve implantation: 10-year outcomes of the NOTION trial. Eur Heart J 45:1116\u20131124 (PMID: 38321820)","journal-title":"Eur Heart J"},{"key":"2630_CR6","doi-asserted-by":"publisher","first-page":"87","DOI":"10.4244\/AIJ-D-22-00067","volume":"9","author":"H Hioki","year":"2023","unstructured":"Hioki H, Watanabe Y, Kawashima H, Otsuka T, Omiya J, Kito K, Katayama T, Kataoka A, Yokoyama N, Kozuma K (2023) Predictors of bioprosthetic valve dysfunction after transcatheter aortic valve implantation. AsiaIntervention. 9:87\u201394. https:\/\/doi.org\/10.4244\/AIJ-D-22-00067","journal-title":"AsiaIntervention."},{"key":"2630_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.jcmg.2015.10.026","volume":"9","author":"V Dayan","year":"2016","unstructured":"Dayan V, Vignolo G, Soca G, Paganini JJ, Brusich D, Pibarot P (2016) Predictors and outcomes of prosthesis-patient mismatch after aortic valve replacement. JACC Cardiovasc Imaging. 9:924\u201333. https:\/\/doi.org\/10.1016\/j.jcmg.2015.10.026","journal-title":"JACC Cardiovasc Imaging."},{"key":"2630_CR8","doi-asserted-by":"publisher","first-page":"e005013","DOI":"10.1161\/CIRCINTERVENTIONS.117.005013","volume":"10","author":"V Mauri","year":"2017","unstructured":"Mauri V, Kim WK, Abumayyaleh M, Walther T, Moellmann H, Schaefer U, Conradi L, Hengstenberg C, Hilker M, Wahlers T et al (2017) Short-term outcome and hemodynamic performance of next-generation self-expanding versus balloon-expandable transcatheter aortic valves in patients with small aortic annulus: a multicenter propensity-matched comparison. Circ Cardiovasc Interv. 10:e005013. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.117.005013","journal-title":"Circ Cardiovasc Interv."},{"key":"2630_CR9","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/ehjci\/jeac188","volume":"24","author":"C Nitsche","year":"2023","unstructured":"Nitsche C, Koschutnik M, Don\u00e0 C, Mutschlechner D, Halavina K, Spinka G, Dannenberg V, Mascherbauer K, Sinnhuber L, Kammerlander A et al (2023) Incidence, causes, correlates, and outcome of bioprosthetic valve dysfunction and failure following transcatheter aortic valve implantation. Eur Heart J Cardiovasc Imaging. 24:796\u2013806. https:\/\/doi.org\/10.1093\/ehjci\/jeac188","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"2630_CR10","doi-asserted-by":"publisher","first-page":"e1269","DOI":"10.4244\/EIJ-D-18-00281","volume":"14","author":"A Mangieri","year":"2018","unstructured":"Mangieri A, Chieffo A, Kim WK et al (2018) Transcatheter aortic valve implantation using the ACURATE neo in bicuspid and tricuspid aortic valve stenosis: a propensity-matched analysis of a European experience. EuroIntervention. 14:e1269\u2013e1275. https:\/\/doi.org\/10.4244\/EIJ-D-18-00281","journal-title":"EuroIntervention."},{"key":"2630_CR11","doi-asserted-by":"publisher","first-page":"e008440","DOI":"10.1161\/JAHA.117.008440","volume":"7","author":"M Barbanti","year":"2018","unstructured":"Barbanti M, Costa G, Zappulla P et al (2018) Incidence of long-term structural valve dysfunction and bioprosthetic valve failure after transcatheter aortic valve replacement. J Am Heart Assoc. 7:e008440. https:\/\/doi.org\/10.1161\/JAHA.117.008440","journal-title":"J Am Heart Assoc."},{"key":"2630_CR12","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.jacc.2018.10.083","volume":"73","author":"L S\u00f8ndergaard","year":"2019","unstructured":"S\u00f8ndergaard L, Ihlemann N, Capodanno D, J\u00f8rgensen TH, Nissen H, Kjeldsen BJ, Chang Y, Steinbr\u00fcchel DA, Olsen PS, Petronio AS, Thyregod HGH (2019) Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. J Am Coll Cardiol. 73:546\u2013553. https:\/\/doi.org\/10.1016\/j.jacc.2018.10.083","journal-title":"J Am Coll Cardiol."},{"key":"2630_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1007\/s00392-022-02052-9","volume":"111","author":"V Veulemans","year":"2022","unstructured":"Veulemans V, Nuyens P, Goh S, Maier O, Binneb\u00f6\u00dfel S, Heermann J, Jung C, Westenfeld R, Kelm M, de Backer O, Zeus T (2022) Bioprosthetic valve dysfunction and failure after TAVI in bicuspid aortic valve stenosis during one-year follow-up according to VARC-3. Clin Res Cardiol. 111:1358\u20131366. https:\/\/doi.org\/10.1007\/s00392-022-02052-9. (Epub 2022 Jun 29)","journal-title":"Clin Res Cardiol."},{"key":"2630_CR14","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","volume":"389","author":"T Chakravarty","year":"2017","unstructured":"Chakravarty T, S\u00f8ndergaard L, Friedman J et al (2017) Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 389:2383\u20132392. https:\/\/doi.org\/10.1016\/S0140-6736(17)30757-2","journal-title":"Lancet."},{"key":"2630_CR15","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.jcin.2023.10.024","volume":"16","author":"Y Choi","year":"2023","unstructured":"Choi Y, Ahn JM, Kang DY, Kim HJ, Kim H, Lee J, Kim M, Park J, Kim KW, Koo HJ et al (2023) Frequency, predictors, and clinical impact of valvular and perivalvular thrombus after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 16:2967\u20132981. https:\/\/doi.org\/10.1016\/j.jcin.2023.10.024","journal-title":"JACC Cardiovasc Interv."},{"key":"2630_CR16","doi-asserted-by":"publisher","first-page":"e014143","DOI":"10.1161\/CIRCINTERVENTIONS.123.014143","volume":"10","author":"KR Chitturi","year":"2024","unstructured":"Chitturi KR, Aladin AI, Braun R, Al-Qaraghuli AK, Banerjee A, Reddy P, Merdler I, Chaturvedi A, Abusnina W, Haberman D et al (2024) Bioprosthetic aortic valve thrombosis: definitions, clinical impact, and management: a state-of-the-art review. Circ Cardiovasc Interv. 10:e014143. https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.123.014143","journal-title":"Circ Cardiovasc Interv."},{"key":"2630_CR17","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1016\/j.jcin.2019.07.027","volume":"12","author":"T Okuno","year":"2019","unstructured":"Okuno T, Khan F, Asami M, Praz F, Heg D, Winkel MG, Lanz J, Huber A, Gr\u00e4ni C, R\u00e4ber L et al (2019) Prosthesis-patient mismatch following transcatheter aortic valve replacement with supra-annular and intra-annular prostheses. JACC Cardiovasc Interv. 12:2173\u20132182. https:\/\/doi.org\/10.1016\/j.jcin.2019.07.027","journal-title":"JACC Cardiovasc Interv."},{"key":"2630_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2312573","author":"HC Herrmann","year":"2024","unstructured":"Herrmann HC, Mehran R, Blackman DJ, Bailey S, M\u00f6llmann H, Abdel-Wahab M, Ben Ali W, Mahoney PD, Ruge H, Wood DA et al (2024) Self-expanding or balloon-expandable TAVR in patients with a small aortic annulus. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMoa2312573","journal-title":"N Engl J Med."},{"key":"2630_CR19","doi-asserted-by":"publisher","first-page":"1175246","DOI":"10.3389\/fcvm.2023.1175246","volume":"10","author":"A Kornyeva","year":"2023","unstructured":"Kornyeva A, Burri M, Lange R, Ruge H (2023) Self-expanding vs balloon-expandable transcatheter heart valves in small aortic annuli. Front Cardiovasc Med 10:1175246. https:\/\/doi.org\/10.3389\/fcvm.2023.1175246","journal-title":"Front Cardiovasc Med"},{"key":"2630_CR20","doi-asserted-by":"publisher","first-page":"924958","DOI":"10.3389\/fcvm.2022.924958","volume":"9","author":"A Scotti","year":"2022","unstructured":"Scotti A, Fovino LN, Coisne A, Fabris T, Cardaioli F, Massussi M, Rodin\u00f2 G, Barolo A, Boiago M, Continisio S et al (2022) 10-Year impact of transcatheter aortic valve replacement leaflet design (intra- versus supra-annular) in mortality and hemodynamic performance. Front Cardiovasc Med 9:924958. https:\/\/doi.org\/10.3389\/fcvm.2022.924958","journal-title":"Front Cardiovasc Med"},{"key":"2630_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.amjcard.2023.01.015","volume":"192","author":"A Bansal","year":"2023","unstructured":"Bansal A, Agarwal S, Braghieri L, Jaggi C, Bakhtadze B, Prasada S, Reed GW, Puri R, Yun J, Menon V, Krishnaswamy A, Kapadia SR (2023) Subclinical leaflet thrombosis after balloon versus self-expandable transcatheter aortic valve implantation. Am J Cardiol. 192:88\u201397. https:\/\/doi.org\/10.1016\/j.amjcard.2023.01.015","journal-title":"Am J Cardiol."},{"key":"2630_CR22","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s12928-020-00675-1","volume":"36","author":"N Prasitlumkum","year":"2021","unstructured":"Prasitlumkum N, Thangjui S, Leesutipornchai T, Kewcharoen J, Limpruttidham N, Pai RG (2021) Comparison of infective endocarditis risk between balloon and self-expandable valves following transcatheter aortic valve replacement: systematic review and meta-analysis. Cardiovasc Interv Ther. 36:363\u2013374. https:\/\/doi.org\/10.1007\/s12928-020-00675-1","journal-title":"Cardiovasc Interv Ther."},{"key":"2630_CR23","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.jcin.2023.01.376","volume":"16","author":"GHL Tang","year":"2023","unstructured":"Tang GHL, Zaid S, Kleiman NS, Goel SS, Fukuhara S, Marin-Cuartas M, Kiefer P, Abdel-Wahab M, De Backer O, S\u00f8ndergaard L et al (2023) Explant vs Redo-TAVR after transcatheter valve failure: mid-term outcomes from the EXPLANTORREDO-TAVR international registry. JACC Cardiovasc Interv. 16:927\u2013941. https:\/\/doi.org\/10.1016\/j.jcin.2023.01.376","journal-title":"JACC Cardiovasc Interv."},{"key":"2630_CR24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1001\/jamacardio.2022.4627","volume":"8","author":"D O'Hair","year":"2023","unstructured":"O\u2019Hair D, Yakubov SJ, Grubb KJ, Oh JK, Ito S, Deeb GM, Van Mieghem NM, Adams DH, Bajwa T, Kleiman NS et al (2023) Structural valve deterioration after self-expanding transcatheter or surgical aortic valve implantation in patients at intermediate or high risk. JAMA Cardiol. 8:111\u2013119. https:\/\/doi.org\/10.1001\/jamacardio.2022.4627","journal-title":"JAMA Cardiol."},{"key":"2630_CR25","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cjca.2023.09.012","volume":"40","author":"T Levesque","year":"2024","unstructured":"Levesque T, Eltchaninoff H, Chabannes R, Barbe T, Dosseh O, Tron C, Bettinger N, Bouhzam N, Hemery T, le Pessec G et al (2024) Impact of prosthesis-patient mismatch after transcatheter aortic valve replacement. Can J Cardiol. 40:113\u2013122. https:\/\/doi.org\/10.1016\/j.cjca.2023.09.012","journal-title":"Can J Cardiol."},{"key":"2630_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/ccd.30818","volume":"102","author":"PP Leone","year":"2023","unstructured":"Leone PP, Regazzoli D, Pagnesi M, Costa G, Teles R, Adamo M, Taramasso M, De Marco F, Mangieri A, Kargoli F, Ohno Y et al (2023) Prosthesis-patient mismatch after transcatheter implantation of contemporary balloon-expandable and self-expandable valves in small aortic annuli. Catheter Cardiovasc Interv. 102:931\u2013943. https:\/\/doi.org\/10.1002\/ccd.30818","journal-title":"Catheter Cardiovasc Interv."},{"key":"2630_CR27","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.jacc.2011.11.048","volume":"59","author":"JM Sinning","year":"2012","unstructured":"Sinning JM, Hammerstingl C, Vasa-Nicotera M et al (2012) Aortic Regurgitation Index defines severity of peri-prosthetic regurgitation and predicts outcome in patients after transcatheter aortic valve implantation. JACC 59:1134\u20131141. https:\/\/doi.org\/10.1016\/j.jacc.2011.11.048","journal-title":"JACC"},{"key":"2630_CR28","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJMoa1200384","volume":"366","author":"SK Kodali","year":"2012","unstructured":"Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR et al (2012) Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 366:1686\u201395. https:\/\/doi.org\/10.1056\/NEJMoa1200384","journal-title":"N Engl J Med"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02630-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02630-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02630-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:32:50Z","timestamp":1780986770000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02630-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2630"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02630-7","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"30 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Verena Veulemans, and Tobias Zeus have received consulting fees, travel expenses, or study honoraria from Medtronic, Edwards Lifesciences and Boston Scientific. Nicolas van Mieghem has grant support from Abbott Vascular, Biotronik, Boston Scientific, Medtronic, Edwards Lifesciences, Abiomed, PulseCath BV, Daiichi Sankyo, Pie Medical. Philipp Seppelt has received consulting fees and travel expenses from Abbott Vascular, Edwards Lifesciences and Boston Scientific. Rutger Jan Nuis received research grant support from Meril, Vifor Pharma and honoraria from Edwards Lifesciences, Abbott, Boston Scientific. Dr Abdel\u2010Wahab discloses that his hospital receives speaker's honoraria and consultancy fees on his behalf from Medtronic, Boston Scientific, and Abbott. All other authors have nothing to disclose with regard to this project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}